Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alpha 1-Antitrypsin - Octapharma

Next Previous
Drug Profile

Alpha 1-Antitrypsin - Octapharma

Alternative Names: OctaAlpha1

Latest Information Update: 28 Jan 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Octapharma
  • Class Acute-phase proteins; Alpha globulins; Anti-inflammatories; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
  • Mechanism of Action Serine endopeptidase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Alpha 1-antitrypsin deficiency

Most Recent Events

  • 28 Jan 2022 No recent reports of development identified for preclinical development in Alpha-1-antitrypsin-deficiency in Switzerland (IV, Infusion)
  • 10 Apr 2018 Octapharma withdraws a phase II trial for alpha1-antitrypsin deficiency prior to enrolment as the IND has been closed (NCT03385395)
  • 28 Dec 2017 Octapharma plans a phase II trial for alpha1-antitrypsin deficiency in July 2018 (NCT03385395)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top